Nicotine metabolism primarily requires spot while in the liver. Consequently, when nicotine is administered with the GI system, it undergoes initial-go metabolism through the liver, resulting in a bioavailability of only about twenty%. This method inherently decreases the bioavailability of nicotine within the process and will induce adverse GI res